Home › NCT06342492

Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All patients older than 18 years of age
* Patients with HFrEF that underwent BVP-CRT
* Experienced CS lead failure, whether initial or recurrent, subsequently replaced with transthoracic epicardial lead placement or CSP
* Underwent Medtronic, Boston Scientific, or Abbott lead placement

Exclusion Criteria:

* Patients younger than 18 years of age
* Transthoracic epicardial lead placement or CSP performed as the initial approach or for other reasons than lead replacement
* Those for which CRT no longer provides symptom relief or mortality benefit.

About the study

This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.

What is being tested

• Coronary Sinus Lead Revision (other)

Sponsor: Kansas City Heart Rhythm Research Foundation · Participants: 100 · Started: Nov 7, 2023

Contact the study team

• Donita Atkins · Phone: 816-651-1969

Official record on ClinicalTrials.gov — NCT06342492

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.